Furosemide Supplier-Buyer Network — Trade Flow Analysis

Name: Furosemide Supplier-Buyer Trade Network Dataset — 333+ Indian Exporters, 15+ Importers, 150+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Furosemide supplier network, Furosemide buyers, pharmaceutical export India, Furosemide trade data

TransData Nexus

Furosemide

India Pharmaceutical Trade Intelligence

$70.5M333 Suppliers150 CountriesHS 30049099

ExportsIndia → UNITED STATES60.2%India → CANADA7.3%

ImportsCANADA → India$79.8K GERMANY → India$43.9K

#1 Supplier: BAXTER PHARMACEUTICALS #1 Buyer: BAXTER HEALTHCARE

Who Supplies Furosemide? Top Manufacturers & Buyers 2026 — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the first-largest Furosemide exporter from India, with a market share of 19.2% and a total export value of $13.6M across 142 shipments. Their average shipment value of $95.4K is above the market average of $15.1K, suggesting premium or bulk contract pricing.

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. BAXTER HEALTHCARE CORPORATION. is the dominant customer, accounting for 84.9% of this supplier's tracked business. Top customers include:

• BAXTER HEALTHCARE CORPORATION. — $11.5M across 121 shipments (84.9% of this supplier's total exports)

• BAXTER HEALTHCARE CORPORATION. — $960.7K across 10 shipments (7.1% of this supplier's total exports)

• STERIMAX INC — $690.3K across 7 shipments (5.1% of this supplier's total exports)

• BAXTER DISTRIBUTION — $259.0K across 3 shipments (1.9% of this supplier's total exports)

• BAXTER HEALTHCARE PT — $139.8K across 1 shipments (1.0% of this supplier's total exports)

Key Insight: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $95.4K is 530% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.

2GRAVITI PHARMACEUTICALS PRIVATE LIMITED

GRAVITI PHARMACEUTICALS PRIVATE LIMITED is the second-largest Furosemide exporter from India, with a market share of 16.6% and a total export value of $11.7M across 1.7K shipments. Their average shipment value of $6.8K is below the market average of $15.1K, reflecting a high-volume, competitive pricing strategy.

GRAVITI PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. RISING PHARMA HOLDINGS INC,., is the dominant customer, accounting for 53.4% of this supplier's tracked business. Top customers include:

• RISING PHARMA HOLDINGS INC,., — $6.3M across 923 shipments (53.4% of this supplier's total exports)

• RISING PHARMA HOLDINGS INC,., — $4.2M across 616 shipments (35.7% of this supplier's total exports)

• RISING PHARMA HOLDINGS INC,., — $980.4K across 145 shipments (8.4% of this supplier's total exports)

• RISING PHARMA HOLDINGS INC,., — $151.7K across 22 shipments (1.3% of this supplier's total exports)

• RISING PHARMA HOLDINGS INC,., — $146.7K across 22 shipments (1.3% of this supplier's total exports)

Key Insight: GRAVITI PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (1.7K shipments) at a per-shipment value of $6.8K, indicating a broad distribution network with many smaller, regular orders.

3PFIZER HEALTHCARE INDIA PRIVATE LIMITED

PFIZER HEALTHCARE INDIA PRIVATE LIMITED is the third-largest Furosemide exporter from India, with a market share of 3.9% and a total export value of $2.8M across 13 shipments. Their average shipment value of $212.9K is above the market average of $15.1K, suggesting premium or bulk contract pricing.

PFIZER HEALTHCARE INDIA PRIVATE LIMITED serves 2 named buyers in our database. HOSPIRA INC is the dominant customer, accounting for 67.8% of this supplier's tracked business. Top customers include:

• HOSPIRA INC — $1.9M across 9 shipments (67.8% of this supplier's total exports)

• XXSPIXX INX — $890.1K across 4 shipments (32.2% of this supplier's total exports)

Key Insight: PFIZER HEALTHCARE INDIA PRIVATE LIMITED's per-shipment value of $212.9K is 1305% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.

4IPCA LABORATORIES LIMITED

IPCA LABORATORIES LIMITED is the fourth-largest Furosemide exporter from India, with a market share of 3.7% and a total export value of $2.6M across 72 shipments. Their average shipment value of $36.0K is above the market average of $15.1K, suggesting premium or bulk contract pricing.

IPCA LABORATORIES LIMITED serves 5 named buyers in our database. NA is the dominant customer, accounting for 66.8% of this supplier's tracked business. Top customers include:

• NA — $1.7M across 48 shipments (66.8% of this supplier's total exports)

• TO THE ORDER — $350.7K across 10 shipments (13.5% of this supplier's total exports)

• MINT PHARMACEUTICALS INC — $271.8K across 8 shipments (10.5% of this supplier's total exports)

• MINT PHARMACEUTICALS INC — $143.9K across 4 shipments (5.6% of this supplier's total exports)

• IPCA LABORATORIES UK — $93.0K across 3 shipments (3.6% of this supplier's total exports)

Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $36.0K is 137% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.

5MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Furosemide exporter from India, with a market share of 3.0% and a total export value of $2.1M across 58 shipments. Their average shipment value of $36.3K is above the market average of $15.1K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. VIATRIS SANTE is the dominant customer, accounting for 69.5% of this supplier's tracked business. Top customers include:

• VIATRIS SANTE — $1.5M across 40 shipments (69.5% of this supplier's total exports)

• VIATRIS SANTE — $241.1K across 7 shipments (11.5% of this supplier's total exports)

• CSP Viatris Sante at — $211.6K across 6 shipments (10.1% of this supplier's total exports)

• CSP VIATRIS SANT? AT — $104.5K across 3 shipments (5.0% of this supplier's total exports)

• CSP VIATRIS SANTE AT — $83.9K across 2 shipments (4.0% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $36.3K is 140% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.

6AVET LIFESCIENCES PRIVATE LIMITED

AVET LIFESCIENCES PRIVATE LIMITED is the fifth-largest Furosemide exporter from India, with a market share of 2.6% and a total export value of $1.8M across 58 shipments. Their average shipment value of $31.9K is above the market average of $15.1K, suggesting premium or bulk contract pricing.

AVET LIFESCIENCES PRIVATE LIMITED serves 3 named buyers in our database. AVET PHARMACEUTICALS INC. is the dominant customer, accounting for 60.4% of this supplier's tracked business. Top customers include:

• AVET PHARMACEUTICALS INC. — $1.1M across 35 shipments (60.4% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER — $570.9K across 18 shipments (30.9% of this supplier's total exports)

• AVET PHARMACEUTICALS INC. — $161.7K across 5 shipments (8.7% of this supplier's total exports)

Key Insight: AVET LIFESCIENCES PRIVATE LIMITED's per-shipment value of $31.9K is 110% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Furosemide imports from India, with a total trade value of $42.5M across 1,889 shipments — representing a 60.2% share of all Furosemide exports. The average shipment value of $22.5K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.

Named Furosemide importers in United States: BAXTER HEALTHCARE CORPORATION is the largest buyer, accounting for 34.0% ($14.4M) of this market's total imports.

• BAXTER HEALTHCARE CORPORATION — $14.4M (34.0% of United States's total)

• RISING PHARMA HOLDINGS, INC. — $6.3M (14.7% of United States's total)

• RISING PHARMA HOLDINGS INC — $4.2M (9.8% of United States's total)

Key Insight: United States's per-shipment average of $22.5K (48% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Furosemide imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Furosemide imports from India, with a total trade value of $5.1M across 53 shipments — representing a 7.3% share of all Furosemide exports. The average shipment value of $96.8K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Furosemide importers in Canada: MARCAN PHARMACEUTICALS INC., is the largest buyer, accounting for 28.8% ($1.5M) of this market's total imports.

• MARCAN PHARMACEUTICALS INC., — $1.5M (28.8% of Canada's total)

• STERIMAX INC — $1.1M (21.9% of Canada's total)

• MINT PHARMACEUTICALS INC — $936.7K (18.3% of Canada's total)

Key Insight: Canada's per-shipment average of $96.8K (539% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Furosemide imports from India.

Primary Market

Secondary Market

3France

France ranks as the third-largest destination for Furosemide imports from India, with a total trade value of $4.3M across 89 shipments — representing a 6.2% share of all Furosemide exports. The average shipment value of $48.9K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Furosemide importers in France: VIATRIS SANTE is the largest buyer, accounting for 36.3% ($1.6M) of this market's total imports.

• VIATRIS SANTE — $1.6M (36.3% of France's total)

• ARROW GENERIQUES, — $1.3M (28.9% of France's total)

Key Insight: France's per-shipment average of $48.9K (223% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Furosemide imports from India.

Primary Market

Secondary Market

4Germany

Germany ranks as the fourth-largest destination for Furosemide imports from India, with a total trade value of $2.1M across 64 shipments — representing a 2.9% share of all Furosemide exports. The average shipment value of $32.2K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Furosemide importers in Germany: SALUTAS PHARMA GMBH is the largest buyer, accounting for 100.0% ($2.1M) of this market's total imports.

• SALUTAS PHARMA GMBH — $2.1M (100.0% of Germany's total)

Key Insight: Germany's per-shipment average of $32.2K (112% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Furosemide imports from India.

Primary Market

Secondary Market

5South Africa

South Africa ranks as the fifth-largest destination for Furosemide imports from India, with a total trade value of $1.6M across 0 shipments — representing a 2.2% share of all Furosemide exports. The average shipment value of $1.6M is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: South Africa's per-shipment average of $1.6M (10332% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Furosemide imports from India.

Primary Market

Secondary Market

People Also Ask — Furosemide Supplier & Trade Network

Who are the top suppliers of Furosemide from India?+

The leading Furosemide suppliers from India are BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED, IPCA LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED, AVET LIFESCIENCES PRIVATE LIMITED. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the market leader with a 19.2% share, exporting $13.6M worth of Furosemide across 142 verified shipments. Together these suppliers cover the majority of India's Furosemide export volume.

Which companies buy Furosemide from Indian manufacturers?+

Named buyers of Furosemide from India include BAXTER HEALTHCARE CORPORATION., BAXTER HEALTHCARE CORPORATION., RISING PHARMA HOLDINGS INC,.,, RISING PHARMA HOLDINGS INC,.,, HOSPIRA INC, XXSPIXX INX, MINT PHARMACEUTICALS INC, and more. These are pharmaceutical companies, distributors, and healthcare procurement organisations operating across 5 countries. United States is the largest receiving market.

Where does Furosemide exported from India go?+

Furosemide from India is exported to 5 major destination countries. Top import markets are United States (60.2%), Canada (7.3%), France (6.2%), Germany (2.9%). The total export value across all destinations is $70.5M from 4,657 shipments.

What is the market share of the top Furosemide supplier from India?+

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED holds the largest market share at 19.2%, with $13.6M in total exports and 142 shipments. Their average per-shipment value is $95.4K. The second-largest supplier, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, holds 16.6%.

What is the average shipment value for Furosemide exports from India?+

The average Furosemide shipment value from India is $15.1K, based on 4.7K total shipments worth $70.5M combined. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, the top exporter, averages $95.4K per shipment — above the market average.

Is Furosemide manufactured in India and exported globally?+

Yes — India is one of the world's largest exporters of Furosemide. Verified shipment records track exports from 333 major Indian manufacturers to buyers in over 5 countries. Key exporters include BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED. The total documented export value is $70.5M.

Which country imports the most Furosemide from India?+

United States is the largest importer of Furosemide from India, accounting for 60.2% of all exports — a total of $42.5M across 1,889 shipments. Named buyers there include BAXTER HEALTHCARE CORPORATION, RISING PHARMA HOLDINGS, INC., RISING PHARMA HOLDINGS INC.

Who are the buyers of Furosemide in Canada?+

Canada is the second-largest destination for Furosemide imports from India, with a 7.3% market share ($5.1M). Verified importers include MARCAN PHARMACEUTICALS INC.,, STERIMAX INC, MINT PHARMACEUTICALS INC.

How concentrated is the Furosemide supplier market in India?+

The Furosemide export market from India shows moderate concentration. The top supplier, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, controls 19.2% of the market. The top 2 suppliers together account for 35.8% of total exports, while all 333 tracked suppliers collectively represent 49.0%.

How do I find verified buyers for Furosemide in specific countries?+

TransData Nexus provides verified, shipment-level buyer data for Furosemide broken down by country. Each record includes the importing company name, trade value, shipment count, and country. Use the "Buyers by Country" tab on this page to explore country-specific importer lists, or contact TransData Nexus directly for a full export intelligence report covering all 5 destination markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Furosemide.
2.Flow Mapping: 333 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,657 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 150 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4,657 Verified Shipments

333 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Furosemide

Furosemide

Who Supplies Furosemide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Furosemide — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Furosemide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Furosemide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED

2GRAVITI PHARMACEUTICALS PRIVATE LIMITED

3PFIZER HEALTHCARE INDIA PRIVATE LIMITED

4IPCA LABORATORIES LIMITED

5MYLAN LABORATORIES LIMITED

6AVET LIFESCIENCES PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Furosemide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Furosemide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Canada

3France

4Germany

5South Africa

People Also Ask — Furosemide Supplier & Trade Network

Furosemide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology